KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Non-cash Items: 2009-2024

Historic Non-cash Items for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to $403.4 million.

  • Encompass Health's Non-cash Items fell 2016.67% to $95.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $363.4 million, marking a year-over-year decrease of 612.24%. This contributed to the annual value of $403.4 million for FY2024, which is 734.43% up from last year.
  • Per Encompass Health's latest filing, its Non-cash Items stood at $403.4 million for FY2024, which was up 734.43% from $375.8 million recorded in FY2023.
  • In the past 5 years, Encompass Health's Non-cash Items registered a high of $426.5 million during FY2020, and its lowest value of $312.7 million during FY2021.
  • For the 5-year period, Encompass Health's Non-cash Items averaged around $374.7 million, with its median value being $375.8 million (2023).
  • Per our database at Business Quant, Encompass Health's Non-cash Items surged by 12578.08% in 2020 and then crashed by 2668.23% in 2021.
  • Annual analysis of 5 years shows Encompass Health's Non-cash Items stood at $426.5 million in 2020, then fell by 26.68% to $312.7 million in 2021, then increased by 13.56% to $355.1 million in 2022, then increased by 5.83% to $375.8 million in 2023, then rose by 7.34% to $403.4 million in 2024.
  • Its Non-cash Items was $403.4 million in FY2024, compared to $375.8 million in FY2023 and $355.1 million in FY2022.